BLRX

BioLineRX

28 hedge funds and large institutions have $28.5M invested in BioLineRX in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

18% less capital invested

Capital invested by funds: $34.9M → $28.5M (-$6.4M)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$147K
2 +$93K
3 +$63.7K
4
Morgan Stanley
Morgan Stanley
New York
+$31.4K
5
VanEck Associates
VanEck Associates
New York
+$31K

Top Sellers

1 -$1.16M
2 -$1.1M
3 -$168K
4
SM
Sabby Management
Florida
-$164K
5
Renaissance Technologies
Renaissance Technologies
New York
-$126K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.9M
2
$6.58M
3
$2.51M
4
$878K
5
$828K
6
$743K
7
$680K
8
$448K
9
$212K
10
$126K
11
$122K
12
$93K
13
$91K
14
$76K
15
$46K
16
$35K
17
$31K
18
$26K
19
$21K
20
$21K
21
$18K
22
$14K
23
$9K
24
$8K
25
$4K